Lilly antibody combo therapy cuts risk of COVID-19 deaths | Reuters

Lilly antibody combo therapy cuts risk of COVID-19 deaths | Reuters: Eli Lilly and Co said on Tuesday treatment with a combination of two of its antibodies helped significantly reduce risk of hospitalizations and death due to COVID-19 in a late-stage trial.